loader

phase 3 study

LATEST ARTICLES

Retrophin Announces Topline Results from Phase 3 FORT Study

pharmaceutical investing

Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update

pharmaceutical investing

Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor

pharmaceutical investing

VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study

pharmaceutical investing

Onconova Therapeutics Announces License Agreement with Pint Pharma

pharmaceutical investing

Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE

pharmaceutical investing

Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients

Albireo to Receive More than $55 Million in Nondilutive Cash Payments

pharmaceutical investing

Savara Releases Q3 2017 Financial Report

pharmaceutical investing

CorMedix Gives Update on Phase 3 Clinical Program for Neutrolin

Aldeyra Gets Orphan Drug Designation for ADX-102

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES